Indivior PLC (INDV)
USD 9.01
(0.78%)
USD 9.01
(0.78%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 911 Million USD | 27.17% |
| 2022 | 510.55 Million USD | 11.95% |
| 2021 | 456.07 Million USD | -4.92% |
| 2020 | 479.68 Million USD | 8.95% |
| 2019 | 440.28 Million USD | -13.35% |
| 2018 | 508.13 Million USD | -15.58% |
| 2017 | 601.88 Million USD | 15.71% |
| 2016 | 520.15 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 148.3 Million USD | -9.17% |
| 2024 Q3 | 234 Million USD | 57.79% |
| 2024 Q1 | 163.26 Million USD | -11.11% |
| 2023 Q2 | 156.14 Million USD | 9.88% |
| 2023 FY | 649.27 Million USD | 27.17% |
| 2023 Q4 | 183.67 Million USD | -52.6% |
| 2023 Q1 | 142.1 Million USD | -69.37% |
| 2023 Q3 | 387.46 Million USD | 148.14% |
| 2022 FY | 510.55 Million USD | 11.95% |
| 2022 Q4 | 463.99 Million USD | 278.9% |
| 2022 Q3 | 122.45 Million USD | 7.87% |
| 2022 Q2 | 113.52 Million USD | 1.69% |
| 2022 Q1 | 111.64 Million USD | -25.3% |
| 2021 FY | 456.07 Million USD | -4.92% |
| 2021 Q4 | 149.44 Million USD | 0.0% |
| 2020 FY | 479.68 Million USD | 8.95% |
| 2019 FY | 440.28 Million USD | -13.35% |
| 2018 FY | 508.13 Million USD | -15.58% |
| 2017 FY | 601.88 Million USD | 15.71% |
| 2016 FY | 520.15 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -10938.581% |
| Alpha Teknova, Inc. | 45.85 Million USD | -1886.524% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -364.836% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -1931.034% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -472.207% |
| Cosmos Health Inc. | 26.18 Million USD | -3379.651% |
| Journey Medical Corporation | 54.59 Million USD | -1568.682% |
| Embecta Corp. | 528.4 Million USD | -72.407% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | -235.053% |
| Dynavax Technologies Corporation | 219.14 Million USD | -315.706% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | -54.405% |
| Pacira BioSciences, Inc. | 326.37 Million USD | -179.125% |
| PainReform Ltd. | 9.58 Million USD | -9405.426% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -6841.233% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -6841.233% |
| SCYNEXIS, Inc. | 51.84 Million USD | -1657.059% |
| Safety Shot Inc | 12.1 Million USD | -7422.899% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -29582.118% |
| Procaps Group, S.A. | 199.47 Million USD | -356.694% |
| Theratechnologies Inc. | 72.75 Million USD | -1152.13% |
| Harrow Health, Inc. | 89.97 Million USD | -912.526% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -9544.294% |
| Biofrontera Inc. | 39.95 Million USD | -2179.837% |
| DURECT Corporation | 43.71 Million USD | -1983.953% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | -72.208% |
| Cronos Group Inc. | 96.7 Million USD | -842.001% |
| OptiNose, Inc. | 85.1 Million USD | -970.48% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | -292.463% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -2226.769% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 9628.292% |
| Organogenesis Holdings Inc. | 314.13 Million USD | -190.004% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -9261.993% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -2016.608% |
| Radius Health, Inc. | 265.92 Million USD | -242.573% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -6481.463% |
| ProPhase Labs, Inc. | 37.85 Million USD | -2306.742% |
| Phibro Animal Health Corporation | 260.29 Million USD | -249.983% |
| Procaps Group S.A. | 187.24 Million USD | -386.528% |
| Alvotech | 285.43 Million USD | -219.159% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -9172.265% |
| Viatris Inc. | 5.96 Billion USD | 84.73% |
| Rockwell Medical, Inc. | 15.37 Million USD | -5825.589% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -1422.393% |
| SIGA Technologies, Inc. | 22.04 Million USD | -4032.827% |
| Tilray Brands, Inc. | 251.35 Million USD | -262.433% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -1757.743% |
| Shineco, Inc. | 17.94 Million USD | -4975.763% |
| PetIQ, Inc. | 192.72 Million USD | -372.694% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -22725.57% |
| Incannex Healthcare Limited | 30.05 Million USD | -2931.311% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 42.938% |
| Alimera Sciences, Inc. | 62.64 Million USD | -1354.319% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -119376.663% |
| Assertio Holdings, Inc. | 368.58 Million USD | -147.161% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -15378.532% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -5015.526% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -4203.463% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -4229.417% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -452.235% |
| Hempacco Co., Inc. | 7.59 Million USD | -11892.445% |
| Talphera, Inc. | 11.99 Million USD | -7495.464% |
| Alvotech | 285.43 Million USD | -219.159% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -547.412% |
| Lantheus Holdings, Inc. | 344.9 Million USD | -164.134% |
| Currenc Group, Inc. | 24 Million USD | -3695.503% |
| Kamada Ltd. | 45.42 Million USD | -1905.459% |
| Evoke Pharma, Inc. | 12.4 Million USD | -7241.066% |
| Flora Growth Corp. | 10.57 Million USD | -8511.4% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -4229.417% |
| Evolus, Inc. | 189.75 Million USD | -380.083% |
| HUTCHMED (China) Limited | 436.23 Million USD | -108.834% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -491.044% |
| Akanda Corp. | 3.48 Million USD | -26051.799% |